Rising Regulatory Initiatives Drives Climate And Carbon Finance Market Growth

Climate And Carbon Finance Market
Climate And Carbon Finance Market

Climate And Carbon Finance Market, By Market Type (Voluntary Market, Compliance Market), By Project Type (Renewable Energy Projects, Energy Efficiency Projects, Forest Carbon Projects, Methane Capture and Utilization Projects, Waste Management Projects, Agriculture and Land Use Projects, Others), By Buyer Type (Corporates, Governments, Financial Institutions, Non-Governmental Organizations (NGOs), Individuals), By Carbon Market Mechanism (Cap and Trade (Emissions Trading System), Carbon Offsetting (Voluntary Carbon Credits), Carbon Pricing (Carbon Tax or Fee)), By Sector Focus (Energy and Utilities, Transportation, Manufacturing and Industrial Processes, Agriculture and Forestry, Buildings and Construction, Waste Management, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa ) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

The global Climate and Carbon Finance Market is estimated to be valued at US$ 355.44 billion in 2022 and is expected to exhibit a CAGR of 29.3 % over the forecast period as highlighted in a new report published by Coherent Market Insights.

Market Overview

Climate finance should not be misinterpreted with carbon finance as the two are completely dissimilar; climate finance states that funds needed for referring the climate change while carbon finance is the revenue recognized by projects from sale of carbon credits earned.

Competitive Landscape:

Key players involved in the growth of the global Climate and Carbon Finance Market are Climate Finance Partners, Carbon Credit Capital, Natural Capital Partners, ClimateCare, First Climate, Gold Standard, South Pole Group, Climate Trust Capital, ClimatePartner, Carbon Clear, EcoAct, Ecosphere+, Verra, Climate Friendly, and Forest Carbon.

Market Key Drivers:

The rising necessity to decrease the greenhouse gas emission is expected to propel the growth of the global Climate and Carbon Finance for Market. For instance, as per facts and figures around 21% of greenhouse gas emitted releases from electricity.

Increasing international agreements from the key players for the expansion is projected to propel the growth of the global Climate and Carbon Finance Market. For instance, Paris agreement makes a framework for all the regions to notice and observe the climate change collectively.

Covid-19 Impact Analysis:

The Covid-19 outbreak has significantly affected the growth of the global Climate and Carbon Finance for Market due to the rising cases of pandemic as there was the strict imposition of lockdown and the movement of people was reduced due to which the there was a decrease in the usage and transportation of fuels from one region to other, and this led to the decrease in greenhouse gases and carbon emission.

Key Takeaways:

The global Climate and Carbon Finance for Market is expected to exhibit a CAGR of 29.3 % during the forecast period owing to the rising demand of the stakeholders. For instance, the investors are identifying the fiscal risks related to climate change and option for returns in low-carbon and climate-resilient segment.

Among regions, North America, Asia Pacific and Europe anticipated to witness robust growth in the global Climate and Carbon Finance Market due to increasing investments, increasing approvals and launches, rising partnerships and collaborations and increasing growth of greenhouse gases. For instance, Asset Management Funds have introduced the launch of Climate and ESG funds.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more